ZSAN Stock Forecast: Stock price wipes out ~50% in 15 days. Time to sell?
ZSAN Stock Forecast: Latest Price
ZSAN Stock Forecast: Performance Chart
|Stock Name||5 Days||1 Month||6 Month||YTD|
ZSAN Stock Forecast: Latest Tweet
Also read: Pfizer Stock Forecast
ZSAN Stock Forecast: Momentum Summary (Today’s Outlook)
|1. Market Data|
|Google Search Volume||Lower|
|Social Media Sentiment||Neutral|
ZSAN Stock Forecast: Stock Price Target
Realistic Price Targets not available for the stock
ZSAN Stock Forecast: Latest Video
ZSAN Stock Forecast: The Stock Drop Down
- Zosano Pharma Corp. warned on Friday that it will require a significant capital infusion to stay in business, sending shares down 17% to $1.58 in after-hours trade.
- The clinical-stage biopharmaceutical company, which had previously announced the suspension of its lead product candidate program and layoffs, reported a first-quarter net loss of $33.4 million, or $7.86 per share, as it recorded an impairment loss of $25.9 million for the three months ended March 31.
- Zosano stated that it has around $9.9 million in cash as of May 11 and that it would require “significantly more finance to sustain its activities and would not be able to continue as a going concern if further monies are not raised.”
- Led to the resignation of Joseph “Jay” P. Hagan, head of the audit committee, it announced plans to reduce the size of its board.
ZSAN Stock Forecast: Google Trends
ZSAN Stock Forecast: Technical Analysis
|Source||Support (S3)||Resistance (R1)||Recommendation|
|Investing||$ 0.5086||$ 0.5526||Sell|
|Barchart||$ 0.6021||$ 0.1221||Sell|
Note: Crowdwisdom360 collates Predictions and data from all over the net and has no in-house view on the likely trends in the Stocks or Crypto Coins. Please consult a registered investment advisor to guide you on your financial decisions.